Video Upload Options

References

1. Beauchamp NJ, Dalton A, Ramaswami U, Niinikoski H, Mention K, Kenny P, KolhoKL, Raiman J, Walter J, Treacy E, Tanner S, Sharrard M. Glycogen storage disease type IX: High variability in clinical phenotype. Mol Genet Metab. 2007Sep-Oct;92(1-2):88-99.
2. Brushia RJ, Walsh DA. Phosphorylase kinase: the complexity of its regulationis reflected in the complexity of its structure. Front Biosci. 1999 Sep15;4:D618-41. Review.
3. Burwinkel B, Amat L, Gray RG, Matsuo N, Muroya K, Narisawa K, Sokol RJ,Vilaseca MA, Kilimann MW. Variability of biochemical and clinical phenotype inX-linked liver glycogenosis with mutations in the phosphorylase kinase PHKA2gene. Hum Genet. 1998 Apr;102(4):423-9.
4. Burwinkel B, Maichele AJ, Aagenaes O, Bakker HD, Lerner A, Shin YS, StrachanJA, Kilimann MW. Autosomal glycogenosis of liver and muscle due to phosphorylase kinase deficiency is caused by mutations in the phosphorylase kinase beta subunit(PHKB). Hum Mol Genet. 1997 Jul;6(7):1109-15.
5. Burwinkel B, Shiomi S, Al Zaben A, Kilimann MW. Liver glycogenosis due tophosphorylase kinase deficiency: PHKG2 gene structure and mutations associatedwith cirrhosis. Hum Mol Genet. 1998 Jan;7(1):149-54.
6. Herbert M, Goldstein JL, Rehder C, Austin S, Kishnani PS, Bali DS.Phosphorylase Kinase Deficiency. 2011 May 31 [updated 2018 Nov 1]. In: Adam MP,Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, Amemiya A, editors.GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle;1993-2020. Available from http://www.ncbi.nlm.nih.gov/books/NBK55061/
7. Wuyts W, Reyniers E, Ceuterick C, Storm K, de Barsy T, Martin JJ. Myopathy andphosphorylase kinase deficiency caused by a mutation in the PHKA1 gene. Am J Med Genet A. 2005 Feb 15;133A(1):82-4.